TG Therapeutics
Commercializes BRIUMVI while developing B-cell therapies for immune-mediated diseases.
$53.93
After-hours close+0.02 (+0.04%)
At close$53.91(−3.25%)
Something off on this page? Send us feedback.
Breakdown13F · Form 4
Institutions 79.56%121.79M sharesInsiders 7.54%11.54M sharesOther 12.90%19.75M shares
Shares outstanding 153.08M · Float 135.10M · 88.3% free float
Institutions13F, as of Jun 30, 2026
461 holders · 121.79M shares · 107 new positions · 256 increased · 125 reduced · 41 closed
| Holder | Shares | % outstanding | Chg q/q | Filed |
|---|---|---|---|---|
| BlackRock, Inc. | 22.05M | 14.40% | −202.9K | Aug 7, 2026 |
| Vanguard Portfolio Management LLC | 7.96M | 5.20% | −310.7K | Aug 13, 2026 |
| State Street Corp | 7.79M | 5.09% | −863.3K | Aug 7, 2026 |
| Vanguard Capital Management LLC | 6.15M | 4.02% | −453.9K | Aug 13, 2026 |
| Geode Capital Management, LLC | 3.64M | 2.38% | +142.3K | Aug 12, 2026 |
| D. E. Shaw & Co., Inc. | 3.40M | 2.22% | +2.81M | Aug 14, 2026 |
| Soleus Capital Management, L.P. | 2.93M | 1.91% | −1.10M | Aug 11, 2026 |
| Price T Rowe Associates Inc /MD/ | 2.77M | 1.81% | +2.13M | Aug 14, 2026 |
Beneficial owners13D/G · 5% or more, as filed
| Holder | % of class | Shares | Form | Filed |
|---|---|---|---|---|
| BlackRock, Inc. | 12.80% | 20.13M | 13G | Apr 30, 2025 ↗ |
| Vanguard Portfolio Management | 5.26% | 8.40M | 13G | Apr 29, 2026 ↗ |
| State Street Corporation | 5.10% | 8.10M | 13G | Nov 10, 2025 ↗ |
InsidersForm 4
| Insider | Role | Shares | % outstanding | Filed |
|---|---|---|---|---|
| Michael S. Weiss | director, officer: CEO | 9.78M | 6.39% | Jan 9, 2026 |
| Sean A. Power | officer: CFO | 798.1K | 0.52% | Jan 9, 2026 |
| Kenneth Hoberman | director | 279.7K | 0.18% | Jun 16, 2025 |
| Yann Echelard | director | 223.8K | 0.15% | Nov 25, 2025 |
| Daniel Hume | director | 192.7K | 0.13% | Jun 16, 2025 |
| Laurence N. Charney | director | 173.6K | 0.11% | Aug 7, 2026 |
| Sagar Lonial | director | 94.1K | 0.06% | Sep 12, 2025 |
4 ten-percent owners hold 20.25M shares by Form 4, outside the officers-and-directors figure above · 13 people have not refiled in the last 18 months (316.4K shares), so they are not in the figure above
Latest trades
| Date | Insider | Type | Shares | Avg price | Owned after |
|---|---|---|---|---|---|
| Nov 24, 2025 | Yann Echelarddirector | Sale | 5,000 | $32.57 | 223,816 |
| Sep 11, 2025 | Sagar Lonialdirector | Sale | 20,852 | $32.24 | 94,061 |
CongressHouse and Senate disclosures
Not reported.